FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,508,000 | -68.7% | 67,300 | -65.4% | 0.20% | -72.7% |
| Q2 2022 | $4,817,000 | -39.7% | 194,400 | -5.6% | 0.75% | -27.1% |
| Q1 2022 | $7,983,000 | +1650.7% | 205,900 | +2539.7% | 1.03% | +2139.1% |
| Q4 2021 | $456,000 | -26.6% | 7,800 | +14.2% | 0.05% | -43.9% |
| Q4 2020 | $621,000 | +60.1% | 6,830 | -29.7% | 0.08% | -60.2% |
| Q3 2020 | $388,000 | -65.7% | 9,712 | -70.6% | 0.21% | -68.1% |
| Q2 2020 | $1,132,000 | +407.6% | 33,000 | +189.5% | 0.64% | +200.0% |
| Q4 2019 | $223,000 | – | 11,400 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |